Heavy-Chain BsAbs More Manufacturable than Light-Chains

Positive

AI Analysis

Summary

Article discusses manufacturing challenges and advantages of heavy-chain bispecific antibodies compared to light-chain variants, addressing yield, stability, and aggregation issues in biomanufacturing.

Importance:3/10

Sentiment:

0.30

bispecific antibodiesmanufacturingheavy-chainlight-chainyieldschain mispairinganalytical characterization

Related Companies

$TRAX

Read the original article

Published by GEN - Genetic Engineering & Biotech News on May 6, 2026 4:00 PM

Read Original